Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Yunsik Choi; Sanghyuk Lee; Kapyoul Kim; Soo Hyun Kim; Yeun Jun Chung; Charles Lee

doi:10.1038/s12276-018-0115-0

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Yunsik Choi, Sanghyuk Lee, Kapyoul Kim, Soo Hyun Kim, Yeun Jun Chung, Charles Lee

Department of Life Science

Research output: Contribution to journal › Review article › peer-review

109 Scopus citations

Abstract

Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.

Original language	English
Article number	99
Journal	Experimental and Molecular Medicine
Volume	50
Issue number	8
DOIs	https://doi.org/10.1038/s12276-018-0115-0
State	Published - 1 Aug 2018

Bibliographical note

Publisher Copyright:
© 2018, The Author(s).

Access to Document

10.1038/s12276-018-0115-0

Cite this

@article{3b56a053554845e997d78ba4df052b33,

title = "Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice",

abstract = "Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient{\textquoteright}s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.",

author = "Yunsik Choi and Sanghyuk Lee and Kapyoul Kim and Kim, {Soo Hyun} and Chung, {Yeun Jun} and Charles Lee",

note = "Publisher Copyright: {\textcopyright} 2018, The Author(s).",

year = "2018",

month = aug,

day = "1",

doi = "10.1038/s12276-018-0115-0",

language = "English",

volume = "50",

journal = "Experimental and Molecular Medicine",

issn = "1226-3613",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

AU - Choi, Yunsik

AU - Lee, Sanghyuk

AU - Kim, Kapyoul

AU - Kim, Soo Hyun

AU - Chung, Yeun Jun

AU - Lee, Charles

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.

AB - Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=85052735086&partnerID=8YFLogxK

U2 - 10.1038/s12276-018-0115-0

DO - 10.1038/s12276-018-0115-0

M3 - Review article

C2 - 30089794

AN - SCOPUS:85052735086

SN - 1226-3613

VL - 50

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

IS - 8

M1 - 99

ER -

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this